Deferasirox Tablets

Product/Composition Deferasirox Tablets
Strength 500mg
Form Tablets
Production Capacity 10 Million Tablets/Month
Packaging 1 X 10 Tablets / Box
Therapeutic use Anti Cancer
Package Insert/Leaflet Available upon request

Deferasirox Tablets are a medicine used as an iron chelator, which means they help remove excess iron from the body.

Here are the key details:

  • Composition: Each tablet contains Deferasirox as the active ingredient, available in different strengths such as 90 mg, 180 mg, and 360 mg.

  • Dosage Form: Oral tablets, often available as film-coated tablets or dispersible tablets.

  • Mode of Action: Deferasirox binds to excess iron in the blood (especially iron that accumulates after frequent blood transfusions) and forms a complex that is excreted mainly through the stool. This reduces harmful iron overload in vital organs.

  • Uses:

    • Treatment of chronic iron overload in patients receiving regular blood transfusions (such as those with thalassemia major, sickle cell anemia, or other chronic anemias).

    • Sometimes used in patients with non-transfusion-dependent thalassemia who develop iron overload.

  • Treatment Goal: To prevent long-term organ damage (like to the liver, heart, and endocrine system) caused by excess iron accumulation.

  • Side Effects:

    • Common: nausea, vomiting, abdominal pain, constipation, diarrhea, rash.

    • Serious: kidney problems, liver problems, hearing or vision disturbances, gastrointestinal bleeding.

  • Precautions:

    • Requires regular monitoring of kidney and liver function.

    • Blood iron levels (serum ferritin) should be checked regularly to adjust dosage.

    • Not recommended in patients with severe kidney or liver impairment.

    • Caution with other medicines that affect kidney or liver.

    • Not generally advised during pregnancy unless clearly needed.